855 related articles for article (PubMed ID: 17169498)
1. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
2. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
[TBL] [Abstract][Full Text] [Related]
3. Role of C5a in inflammatory responses.
Guo RF; Ward PA
Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
[TBL] [Abstract][Full Text] [Related]
4. [Complement activation and inflammation].
Abe M
Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
[TBL] [Abstract][Full Text] [Related]
5. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
7. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion.
Caldwell CC; Okaya T; Martignoni A; Husted T; Schuster R; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G969-76. PubMed ID: 16002566
[TBL] [Abstract][Full Text] [Related]
8. Natural antibody mediated innate autoimmune response.
Zhang M; Carroll MC
Mol Immunol; 2007 Jan; 44(1-3):103-10. PubMed ID: 16876247
[TBL] [Abstract][Full Text] [Related]
9. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
[TBL] [Abstract][Full Text] [Related]
11. Complement mediators in ischemia-reperfusion injury.
Arumugam TV; Magnus T; Woodruff TM; Proctor LM; Shiels IA; Taylor SM
Clin Chim Acta; 2006 Dec; 374(1-2):33-45. PubMed ID: 16872589
[TBL] [Abstract][Full Text] [Related]
12. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
13. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
Sunyer JO; Boshra H; Li J
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
[TBL] [Abstract][Full Text] [Related]
14. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
15. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
[TBL] [Abstract][Full Text] [Related]
16. C5a and Fcgamma receptors: a mutual admiration society.
Atkinson JP
J Clin Invest; 2006 Feb; 116(2):304-6. PubMed ID: 16453017
[TBL] [Abstract][Full Text] [Related]
17. Innate autoimmunity.
Carroll MC; Holers VM
Adv Immunol; 2005; 86():137-57. PubMed ID: 15705421
[TBL] [Abstract][Full Text] [Related]
18. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of ischemia/reperfusion-associated tissue damage.
Ioannou A; Dalle Lucca J; Tsokos GC
Clin Immunol; 2011 Oct; 141(1):3-14. PubMed ID: 21839685
[TBL] [Abstract][Full Text] [Related]
20. The role of C5a in the innate immune response after experimental blunt chest trauma.
Flierl MA; Perl M; Rittirsch D; Bartl C; Schreiber H; Fleig V; Schlaf G; Liener U; Brueckner UB; Gebhard F; Huber-Lang MS
Shock; 2008 Jan; 29(1):25-31. PubMed ID: 17621257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
